Tofacitinib Citrate
Preliminary reference disclaimer
This preliminary safety reference is generated from structured MolGraph catalog fields and public reference-style data. It is not a supplier-issued Safety Data Sheet and should not be used as a substitute for supplier-issued documentation, workplace safety review, transport classification, or regulatory compliance decisions. For supplier SDS or COA, submit a documentation request through MolGraph.
Preliminary safety reference
Available
Supplier-issued SDS
Available by request
COA
Available by RFQ / lot confirmation
Transport classification
Requires shipment review
CAS Number
540737-29-9
Chemical name
Tofacitinib Citrate
Molecular formula
C22H28N6O8
Molecular weight
504.5 g/mol
Synonyms
Tasocitinib citrate; Xeljanz; CP-690550 citrate; Xeljanz Xr; Tasocitinib monocitrate; CP-690,550-10; Tofacitinib monocitrate; 1-PIPERIDINEPROPANENITRILE, 4-METHYL-3-(METHYL-7H-PYRROLO(2,3-D)PYRIMIDIN-4-YLAMINO)-beta-OXO-, (3R,4R)-, 2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE (1:1); 1-PIPERIDINEPROPANENITRILE, 4-METHYL-3-(METHYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YLAMINO)-BETA-OXO-, (3R,4R)-, 2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE (1:1); Tofacitinib (CP-690550) Citrate; Tofacitinib (citrate); Tofacitinib citrate [USAN]
InChIKey
SYIKUFDOYJFGBQ-YLAFAASESA-N
PubChem CID
10174505
Signal word
Warning
Catalog reference cue; confirm supplier documentation before use.
Hazard statements
H302, H315, H319, H335
Catalog reference cue; confirm supplier documentation before use.
Physical property reference values are not available in the current MolGraph catalog record.
Shipment review
Shipment details require review before fulfillment.
Transport classification must be confirmed using supplier SDS and shipment documentation before dispatch.